Pfizer wins FDA approval for hemophilia B drug that will be first once-weekly treatment

The new drug would allow patients to produce the needed clotting protein for an extended period, reducing the need for constant intravenous infusions or injections, which are painful as well as inconvenient.

Source: MarketWatch

Continue reading...